Comprehensive investigation identifies CPSF3 as a novel prognostic and oncogenic biomarker in bladder cancer
CPSF3 is a promising prognostic biomarker for BC and may play a crucial role in BC progression. Incorporating CPSF3 into clinical prognostic models may enhance prediction of patient outcomes. CPSF3 may represent a promising therapeutic target for BC management.
Authors
- Chenghe Wang (ORCID: https://orcid.org/0000-0002-1869-8676)
- Wei He (ORCID: https://orcid.org/0000-0002-2755-9504)
- Zhiyang Ma (ORCID: https://orcid.org/0000-0003-3263-2785)
- Yining Hao (ORCID: https://orcid.org/0000-0002-4066-048X)
- Xin Xie (ORCID: https://orcid.org/0000-0002-6031-4808)
- Dan-feng Xu
Institutions
- Ruijin Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-10
- DOI
- https://doi.org/10.1007/s12672-025-03672-z
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.04